Atorvastatin counteracts aberrant soft tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6 -/- )

Journal of Molecular Medicine

Volumn 91, Issue 10, 2013, Pages 1177-1184

  Guo, Haitao ^a,b   Li, Qiaoli ^a   Chou, David W ^a   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ectopic mineralization; Pseudoxanthoma elasticum; Statin therapy

Indexed keywords

ATORVASTATIN; CALCIUM; CHOLESTEROL; PHOSPHATE; PROTEIN; PROTEIN ABCC6; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; HISTOPATHOLOGY; LIPID BLOOD LEVEL; MINERALIZATION; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PSEUDOXANTHOMA ELASTICUM; SOFT TISSUE; TRIACYLGLYCEROL BLOOD LEVEL; VIBRISSA; WILD TYPE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCINOSIS; CALCIUM; CONNECTIVE TISSUE; DERMIS; DISEASE MODELS, ANIMAL; GENOTYPE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MICE; MICE, KNOCKOUT; PSEUDOXANTHOMA ELASTICUM; PYRROLES;

EID: 84885310771     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1066-5     Document Type: Article

References (24)

1. Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP (2013) Cutaneous calciphylaxis: a retrospective histopathologic evaluation. Am J Dermatopathol. doi: 10.1097/DAD.0b013e31827c7f5d
2. van Setten J, Isgum I, Smolonska J, Ripke S, de Jong PA, Oudkerk M, de Koning H, Lammers JW, Zanen P, Groen HJ et al (2013) Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis 228:400-402
3. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS (2007) Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49:1860-1870
4. Rashtchizadeh N, Ghorbanihaghjo A, Argani H, Mahmoudi Meimand S, Safa J, Vatankhahan H, Shahidi M (2012) Serum receptor activator of nuclear factor-kappa B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. Ther Apher Dial 16:600-604
5. Poggio P, Grau JB, Field BC, Sainger R, Seefried WF, Rizzolio F, Ferrari G (2011) Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls. J Cell Physiol 226:2139-2149
6. Li Q, Uitto J (2013) Mineralization/anti-mineralization networks in the skin and vascular connective tissues. Am J Pathol. doi: 10.1016/j.ajpath.2013. 03.002
7. Neldner KH (1988) Pseudoxanthoma elasticum. Clin Dermatol 6:1-159
8. Uitto J, Li Q, Jiang Q (2010) Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J Invest Dermatol 130:661-670
9. Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT, van Kuppevelt TH, Levelt CN, de Wolf A, Loves WJ et al (2005) Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14:1763-1773
10. Klement JF, Matsuzaki Y, Jiang QJ, Terlizzi J, Choi HY, Fujimoto N, Li K, Pulkkinen L, Birk DE, Sundberg JP et al (2005) Targeted ablation of the Abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25:8299-8310
11. Uitto J, Varadi A, Bercovitch L, Terry PF, Terry SF (2013) Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE International Research Meeting. J Invest Dermatol 133:1444-1449
12. Wegman JJ, Hu X, Tan H, Bergen AA, Trip MD, Kastelein JJ, Smulders YM (2005) Patients with premature coronary artery disease who carry the ABCC6 R1141X mutation have no pseudoxanthoma elasticum phenotype. Int J Cardiol 100:389-393
13. Trip MD, Smulders YM, Wegman JJ, Hu X, Boer JM, ten Brink JB, Zwinderman AH, Kastelein JJ, Feskens EJ, Bergen AA (2002) Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation 106:773-775
14. Köblös G, Andrikovics H, Prohászka Z, Tordai A, Váradi A, Arányi T (2010) The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease. Genet Test Mol Biomark 14:75-78
15. Jiang Q, Li Q, Uitto J (2007) Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 127:1392-1402
16. Park JB, Zhang H, Lin CY, Chung CP, Byun Y, Park YS, Yang VC (2012) Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors alpha. J Surg Res 174:278-283
17. Benoit DS, Nuttelman CR, Collins SD, Anseth KS (2006) Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 27:6102-6110
18. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N (2004) Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 92:458-471
19. Horiuchi N, Maeda T (2006) Statins and bone metabolism. Oral Dis 12:85-101
20. Maritz FJ, Conradie MM, Hulley PA, Gopal R, Hough S (2001) Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc 21:1636-1641
21. Kavukcuoglu NB, Li Q, Pleshko N, Uitto J (2012) Connective tissue mineralization in Abcc6(-/-) mice, a model for Pseudoxanthoma elasticum. Matrix Biol 31:246-252
22. Li Q, Guo H, Chou D, Harrington D, Schurgers LJ, Terry SF, Uitto J (2013) Warfarin accelerates ectopic mineralization in Abcc6-/- mice - clinical relevance to pseudoxanthoma elasicum. Am J Pathol 182:1139-1150
23. van De Poll SW, Romer TJ, Volger OL, Delsing DJ, Bakker Schut TC, Princen HM, Havekes LM, Jukema JW, van Der Laarse A, Puppels GJ (2001) Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice. Arterioscler Thromb Vasc 21:1630-1635
24. van de Poll SW, Delsing DJ, Wouter Jukema J, Princen HM, Havekes LM, Puppels GJ, van der Laarse A (2003) Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice. J Mol Cell Cardiol 35:109-118